John Bingham Selected Research

John Bingham Research Topics

Disease

17	Infections 01/2022 - 03/2007
6	Rabies (Hydrophobia) 01/2022 - 03/2002
4	Influenza in Birds (Avian Flu) 01/2018 - 03/2007
3	Neoplasms (Cancer) 01/2023 - 04/2011
3	Henipavirus Infections 10/2009 - 12/2006
2	COVID-19 01/2022 - 05/2021
2	Human Influenza (Influenza) 01/2018 - 04/2011
2	Virus Diseases (Viral Diseases) 11/2011 - 08/2007
1	Lymphoma (Lymphomas) 01/2023
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2023
1	Newcastle Disease 01/2017
1	African Swine Fever 01/2017
1	Viremia 01/2016
1	Cytokine Release Syndrome 06/2014
1	Paralysis (Palsy) 06/2014
1	Meningoencephalitis 06/2014
1	Seizures (Absence Seizure) 06/2014
1	Pain (Aches) 04/2014
1	Chronic Pain 04/2014
1	Inflammation (Inflammations) 01/2011
1	Fever (Fevers) 01/2008
1	Urinary Bladder Neoplasms (Bladder Cancer) 10/2007
1	Infarction (Infarctions) 06/2003
1	Lumpy Skin Disease 06/2002

Drug/Important Bio-Agent (IBA)

5	VaccinesIBA 01/2022 - 06/2002
5	AntigensIBA 01/2018 - 03/2002
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2010
3	CytokinesIBA 06/2014 - 01/2011
2	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2016
2	Messenger RNA (mRNA)IBA 01/2020 - 01/2014
2	Acute-Phase Proteins (Acute-Phase Protein)IBA 06/2014 - 01/2011
2	Neutralizing AntibodiesIBA 10/2009 - 01/2008
1	loncastuximab tesirineIBA 01/2023
1	pyrrolo(2,1-c)(1,4)benzodiazepineIBA 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	Immunoconjugates (Immunoconjugate)IBA 01/2023
1	IminesIBA 01/2023
1	NucleoproteinsIBA 01/2022
1	ChAdOx1 nCoV-19IBA 05/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 07/2020
1	Chemokine CXCL10IBA 01/2020
1	ChemokinesIBA 01/2020
1	Basic Amino Acids (Basic Amino Acid)IBA 01/2018
1	Hemagglutinins (Hemagglutinin)IBA 01/2018
1	AcetoneIBA 11/2017
1	Formaldehyde (Formol)FDA Link 11/2017
1	RNA (Ribonucleic Acid)IBA 01/2017
1	AerosolsIBA 11/2015
1	Interleukin-6 (Interleukin 6)IBA 06/2014
1	A-factor (Streptomyces)IBA 06/2014
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 06/2014
1	LigandsIBA 01/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2014
1	AntibodiesIBA 07/2012
1	RestonIBA 11/2011
1	InterleukinsIBA 04/2011
1	Interleukin-4 (Interleukin 4)IBA 04/2011
1	Interleukin-10 (Interleukin 10)IBA 04/2011
1	Interleukin-12 (IL 12)IBA 04/2011
1	InterferonsIBA 04/2011
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2011
1	EnzymesIBA 01/2011
1	Oxidants (Oxidizing Agents)IBA 01/2011
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2011
1	Monoclonal AntibodiesIBA 10/2009
1	ElementsIBA 09/2007
1	Caspase 3 (Caspase-3)IBA 08/2007
1	CaspasesIBA 08/2007
1	Caspase 9IBA 08/2007
1	Caspase 8 (Caspase-8)IBA 08/2007
1	Inactivated VaccinesIBA 03/2007
1	Subunit VaccinesIBA 12/2006
1	Glycoproteins (Glycoprotein)IBA 12/2006
1	Lysergic Acid Diethylamide (LSD)IBA 06/2002
1	Synthetic Vaccines (Recombinant Vaccines)IBA 06/2002

Therapy/Procedure

3	Therapeutics 01/2022 - 04/2014
1	Critical Care (Surgical Intensive Care) 01/2022
1	Investigational Therapies (Experimental Therapy) 01/2022
1	Proton Therapy 03/2016
1	Sensory Art Therapies 04/2014
1	Drug Therapy (Chemotherapy) 04/2011
1	Cystectomy 10/2007
1	Renal Dialysis (Hemodialysis) 06/2003